Literature DB >> 19796734

The role of cardiovascular magnetic resonance imaging in heart failure.

Theodoros D Karamitsos1, Jane M Francis, Saul Myerson, Joseph B Selvanayagam, Stefan Neubauer.   

Abstract

Noninvasive imaging plays a central role in the diagnosis of heart failure, assessment of prognosis, and monitoring of therapy. Cardiovascular magnetic resonance (CMR) offers a comprehensive assessment of heart failure patients and is now the gold standard imaging technique to assess myocardial anatomy, regional and global function, and viability. Furthermore, it allows assessment of perfusion and acute tissue injury (edema and necrosis), whereas in nonischemic heart failure, fibrosis, infiltration, and iron overload can be detected. The information derived from CMR often reveals the underlying etiology of heart failure, and its high measurement accuracy makes it an ideal technique for monitoring disease progression and the effects of treatment. Evidence on the prognostic value of CMR-derived parameters in heart failure is rapidly emerging. This review summarizes the advantages of CMR for patients with heart failure and its important role in key areas.

Entities:  

Mesh:

Year:  2009        PMID: 19796734     DOI: 10.1016/j.jacc.2009.04.094

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  115 in total

Review 1.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

Review 2.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 3.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

4.  Classification of diastolic function with phase-contrast cardiac magnetic resonance imaging: validation with echocardiography and age-related reference values.

Authors:  Sebastian J Buss; Birgit Krautz; Bernhardt Schnackenburg; Hassan Abdel-Aty; Maria Fernanda Braggion Santos; Florian Andre; Malte J Maertens; Derliz Mereles; Grigorios Korosoglou; Evangelos Giannitsis; Hugo A Katus; Henning Steen
Journal:  Clin Res Cardiol       Date:  2014-01-23       Impact factor: 5.460

5.  Spiral tissue phase velocity mapping in a breath-hold with non-cartesian SENSE.

Authors:  Robin Simpson; Jennifer Keegan; Peter Gatehouse; Michael Hansen; David Firmin
Journal:  Magn Reson Med       Date:  2013-10-07       Impact factor: 4.668

Review 6.  [Indications for magnetic resonance imaging in Internal Medicine. When do we really need this technology?].

Authors:  A G Schreyer; K Debl; H Herfarth
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

Review 7.  Cardiovascular magnetic resonance in heart failure.

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

8.  Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach.

Authors:  Johannes H Riffel; Marius G P Keller; Matthias Aurich; Yannick Sander; Florian Andre; Sorin Giusca; Fabian Aus dem Siepen; Sebastian Seitz; Christian Galuschky; Grigorios Korosoglou; Derliz Mereles; Hugo A Katus; Sebastian J Buss
Journal:  Clin Res Cardiol       Date:  2015-02-03       Impact factor: 5.460

9.  Foreword.

Authors:  Andrew Js Coats; Giuseppe Rosano
Journal:  Card Fail Rev       Date:  2016-05

Review 10.  The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.